HC Wainwright Reiterates Buy Rating for First Wave BioPharma (NASDAQ:FWBI)

Retrieved on: 2022-11-02 06:27:06

Tags for this article:

Finance

Occupations

Securities research

Citigroup

Economy of New York City

Service industries

BioPharma Inc.

Click the tags to see associated articles and topics

HC Wainwright Reiterates Buy Rating for First Wave BioPharma (NASDAQ:FWBI). View article details on hiswai:

Excerpt

First Wave BioPharma (NASDAQ:FWBI – Get Rating)'s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research ...

Article found on: reporter.am

View Original Article